Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00972907Phase 2Completed
A Phase 2 trial of nifedipine in chronic anal fissure (CAF), sponsored by RDD Pharma. Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00972907.